文档介绍：JOURNAL OF RARE AND UNCOMMON DISEASES, MAY. 2022,, , Total
·论著·
艾司西酞普兰联合坦度螺***治疗老年女性冠心病继发焦虑抑郁phic factor (BDNF), Serum Myelin Peroxidase (MPO), and Serum lipoprotein (LP)),
and laboratory indicators [NT-proBNP, CK-MB, hs-CRP]. Results Before the treatment, Two-group NT-proBNP, CK-MB, hs-CRP level comparison
(P>), After the treatment, the study group NT-proBNP, CK-MB, hs-CRP was below the control group (P<); Before the treatment, two
groups of MPO and BDNF comparison (P>)After the treatment, the study group MPO was significantly lower than in the control group, while
BDNF is significantly higher than (P<); Before the treatment, comparison of HAMD and HAMA (P>).After the treatment, both the HAMD
and HAMA scores were significantly lower than in the control group (P<). Conclusion Elderly patients with escitalopram combined with
tanspironone can inhibit inflammation, reduce myocardial injury, promote neurotransmitter secretion and finally improve mood disorders
Keywords: Escitalopram; Andu Spironone; Women; Coronary Heart Disease; Anxiety and Depression Disorder
[4]
　　冠心病是临床常见心血管疾病，好发于老年群体，对对降低心血管不良事件